| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5529791 | BIOVAIL | Extended release form of diltiazem |
Jun, 2013
(10 years ago) | |
Diltiazem Hydrochloride is owned by Biovail.
Diltiazem Hydrochloride contains Diltiazem Hydrochloride.
Diltiazem Hydrochloride has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Diltiazem Hydrochloride are:
- US5529791
Diltiazem Hydrochloride was authorised for market use on 28 January, 2000.
Diltiazem Hydrochloride is available in capsule, extended release;oral dosage forms.
The generics of Diltiazem Hydrochloride are possible to be released after 25 June, 2013.
Drugs and Companies using DILTIAZEM HYDROCHLORIDE ingredient
Market Authorisation Date: 28 January, 2000
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
More Information on Dosage
DILTIAZEM HYDROCHLORIDE family patents
